Acute Gonorrhea:—Proteogen No. 11.—Mr. A. E. R., age 65, weight 140 pounds. First attack. Had had no previous treatment. Came to me January 2, 1919. Had discharge, all acute symptoms, burning, etc. Gave seventeen injections of Proteogen No. 11, also mild antiseptic urethral wash. Discharged on February 15, 1919, clinically cured.—April 11, 1919.
Epithelioma of Buttock.—Proteogen No. 1.—I used Proteogen No. 1 on an epithelioma of buttock some six months ago with favorable results and no return of symptoms as yet.—April 13, 1919.
It is obvious that the Proteogen preparations are in conflict with Rules 1, 6 and 10, and should not be admitted to “New and Nonofficial Remedies.” It is recommended that the previous action of the Council be allowed to stand and that publication of both reports be authorized.—(From The Journal A. M. A., July 12, 1919)
“ARSENOVEN S. S.” AND “ARSENO-METH-HYD”
Report of the Council on Pharmacy and Chemistry
The Council authorizes publication of the following report. This report declares Arsenoven S. S. of the S. S. Products Company and Solution of Arsenic and Mercury (formerly called Arseno-Meth-Hyd) of the New York Intravenous Laboratory, inadmissible to New and Nonofficial Remedies. The Council takes this opportunity to repeat its warning against the abuses—often dangerous—to which patients are frequently subjected when “intravenous therapy” is employed.
W. A. Puckner, Secretary.
Because of inquiries received, the Council took up the consideration of Arsenoven S. S. and Arseno-Meth-Hyd (now sold as Solution of Arsenic and Mercury). The preparations having been referred to a committee for consideration, this committee reported: